bn:02615279n
Noun Concept
Categories: Experimental cancer drugs, Antineoplastic and immunomodulating drug stubs, Drugs not assigned an ATC code, Ureas, Tyrosine kinase inhibitors
EN
linifanib  1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea  ABT-869  ABT869  ABT 869
EN
Linifanib is a structurally novel, potent inhibitor of receptor tyrosine kinases, vascular endothelial growth factor and platelet-derived growth factor with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGF receptor beta, KDR, and colony stimulating factor 1 receptor, respectively. Wikipedia
Definitions
Relations
Sources
EN
Linifanib is a structurally novel, potent inhibitor of receptor tyrosine kinases, vascular endothelial growth factor and platelet-derived growth factor with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGF receptor beta, KDR, and colony stimulating factor 1 receptor, respectively. Wikipedia
An inhibitor of certain receptor tyrosine kinases, vascular endothelial growth factor, and platelet-derived growth factor. Wiktionary